Lake Street Advisors Group LLC Buys 1,377 Shares of Colgate-Palmolive (NYSE:CL)

Lake Street Advisors Group LLC raised its stake in shares of Colgate-Palmolive (NYSE:CL) by 38.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,930 shares of the company’s stock after acquiring an additional 1,377 shares during the period. Lake Street Advisors Group LLC’s holdings in Colgate-Palmolive were worth $444,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Union Savings Bank lifted its position in shares of Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares in the last quarter. Avion Wealth lifted its position in shares of Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after buying an additional 175 shares in the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $32,000. PSI Advisors LLC increased its position in shares of Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after acquiring an additional 348 shares during the last quarter. Finally, Core Wealth Advisors Inc. lifted its holdings in Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after acquiring an additional 146 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 12,226 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded up $0.02 during trading on Wednesday, hitting $96.57. The stock had a trading volume of 4,880,324 shares, compared to its average volume of 4,377,431. The firm has a market cap of $79.23 billion, a price-to-earnings ratio of 30.56, a P/E/G ratio of 3.53 and a beta of 0.39. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $99.63. The business’s 50-day moving average is $95.68 and its 200 day moving average is $89.89. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter last year, the firm posted $0.73 EPS. The company’s revenue was up 6.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.54 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a yield of 2.07%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CL. Barclays lifted their target price on Colgate-Palmolive from $85.00 to $91.00 and gave the stock an “equal weight” rating in a research note on Friday, July 19th. Bank of America boosted their target price on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Evercore ISI raised their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Royal Bank of Canada upped their price objective on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research note on Monday, April 29th. Finally, Jefferies Financial Group downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the stock from $103.00 to $95.00 in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $98.58.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.